Global Conference 2013

America's investment in bioscience, especially through the National Science Foundation and the National Institutes of Health, accelerated for several years beginning in 1998. Today, we're reaping the return on that investment as what once seemed impossible becomes routine. Precision medicine is reducing suffering and deaths, and processes that once took years and cost millions - think sequencing the human genome - get faster and cheaper by the day. But those advances are merely a prologue. We're at the dawn of a scientific revolution that will save, extend and improve the quality of people's lives across the planet while easing the tremendous economic burden of health care. Moreover, bioscience holds promise for solving seemingly intractable global challenges related to energy, access to clean water and sustainable food production. How do we quicken this work? Who will fund it? And how can the participants in the bioscience ecosystem work together more effectively?

Read the blog post


Michael Milken

Chairman, Milken Institute


Eric Cantor

U.S. Congressman and Majority Leader

Paul Chew

Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs, Sanofi

Margaret Hamburg

Commissioner, U.S. Food and Drug Administration

Bernard Harris Jr.

Founder and President, Harris Foundation; CEO and Managing Director, Vesalius Ventures, Inc.

Geoffrey Ling

Deputy Director, Defense Sciences Office, DARPA

Return to Program Detail